[A new treatment for vitiligo: topical Kandil therapy combined with oral P.A.B.A].
D010129:4-Aminobenzoic Acid / Q000008:administration & dosage*; D000284:Administration, Oral; D000287:Administration, Topical; D062365:Aminobenzoates / Q000008:administration & dosage*; D001623:Betamethasone / Q000031:analogs & derivatives*; D001624:Betamethasone Valerate / Q000008:administration & dosage*; D002118:Calcium / Q000008:administration & dosage; D002214:Capsules; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D009824:Ointments; D014820:Vitiligo / Q000188:drug therapy*
D062365:Aminobenzoates; D002214:Capsules; D009824:Ointments; D001623:Betamethasone; D001624:Betamethasone Valerate; D002118:Calcium; D010129:4-Aminobenzoic Acid
Un nuevo tratamiento para el vitíligo: terapia tópica de Kandil combinada con P.A.B.A. oral.